In hematologic malignancies, BRAF mutations have been frequently identified in hairy cell leukemia (HCL), Erdheim–Chester disease, Langerhans cell histiocytosis, and plasma cell neoplasms [2]. This evidence concerns the gene BRAF and hairy cell leukemia.